cysteine has been researched along with 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, GM; Baguley, TD; Brouillette, J; Chatterjee, M; Cuny, GD; Ellman, JA; Foscue, E; Ghosh, D; Glicksman, MA; Greengard, P; Gresack, J; Kanyo, J; Kurup, P; Lam, TT; Lombroso, PJ; Nairn, AC; Ononenyi, C; Seyb, K; Tautz, L; Xu, J; Zhang, Y | 1 |
1 other study(ies) available for cysteine and 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine
Article | Year |
---|---|
Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Animals; Benzothiepins; Catalytic Domain; Cell Death; Cerebral Cortex; Cognition Disorders; Cysteine; Disease Models, Animal; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Neurons; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases, Non-Receptor; Substrate Specificity | 2014 |